1. Academic Validation
  2. Human CRB2 inhibits gamma-secretase cleavage of amyloid precursor protein by binding to the presenilin complex

Human CRB2 inhibits gamma-secretase cleavage of amyloid precursor protein by binding to the presenilin complex

  • J Biol Chem. 2010 May 14;285(20):14920-14931. doi: 10.1074/jbc.M109.038760.
Yachiyo Mitsuishi 1 Hiroshi Hasegawa 1 Akinori Matsuo 1 Wataru Araki 2 Toshiharu Suzuki 3 Shinji Tagami 4 Masayasu Okochi 4 Masatoshi Takeda 4 Ronald Roepman 5 Masaki Nishimura 6
Affiliations

Affiliations

  • 1 Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga 520-2192, Japan.
  • 2 Department of Demyelinating Disease and Aging, National Institute of Neuroscience, NCNP, Tokyo 187-8502, Japan.
  • 3 Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Hokkaido 060-0812, Japan.
  • 4 Department of Post-Genomics and Diseases, Division of Psychiatry and Behavioral Proteomics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • 5 Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen 6500 HB, The Netherlands.
  • 6 Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga 520-2192, Japan. Electronic address: mnishimu@belle.shiga-med.ac.jp.
Abstract

Drosophila Crumbs has been reported to attenuate Notch signaling by inhibition of gamma-secretase cleavage at the wing margins. gamma-Secretase is an intramembrane Protease that is responsible for the generation of amyloid-beta (Abeta) Peptides from the beta-amyloid precursor protein (APP). Here, we re-examined gamma-secretase inhibition by human CRB2, which is the most abundant Crumbs ortholog in the brain. Transfected CRB2 inhibited proteolytic production of Abeta and APP intracellular domains from APP C-terminal fragments in HEK293 and SH-SY5Y cells. Conversely, knockdown of endogenous CRB2 increased gamma-secretase cleavage products in SH-SY5Y cells. CRB2 inhibition of gamma-cleavage was also detected in cell-free assays. CRB2 interacted with the gamma-secretase complex, but was not a competitive substrate for gamma-cleavage. The transmembrane domain of CRB2 was indispensable for inhibition of Abeta generation and mediated CRB2 binding with the gamma-secretase complex. In addition, the cytoplasmic domain appeared to play a supportive role in gamma-secretase inhibition, whereas mutational disruption of the two protein-binding motifs involved in the formation of cell adhesion complexes did not affect gamma-secretase inhibition. Co-overexpression of presenilin-1 or APH-1 abrogated gamma-secretase inhibition probably through prevention of the incorporation of CRB2 into the gamma-secretase complex. Our results suggest that CRB2 functions as an inhibitory binding protein that is involved in the formation of a mature but inactive pool of the gamma-secretase complex.

Figures